Cite
APA Citation
Ohm, L., Lundqvist, A., Dickman, P., Höglund, M., Persson, U., Stenke, L., Carlsson, K. S., & Björkholm, M. (n.d.). real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib. Leukemia & lymphoma, 56(5), 1385–1391. http://access.bl.uk/ark:/81055/vdc_100025996387.0x000061